VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,801,892 | -35.5% | 2,007,946 | 0.0% | 0.61% | -32.8% |
Q2 2023 | $47,769,035 | -6.5% | 2,007,946 | 0.0% | 0.90% | -22.0% |
Q1 2023 | $51,082,146 | +98.7% | 2,007,946 | +128.2% | 1.16% | +121.9% |
Q4 2022 | $25,704,800 | +42.4% | 880,000 | 0.0% | 0.52% | +35.3% |
Q3 2022 | $18,049,000 | +106070.6% | 880,000 | +85006.4% | 0.38% | – |
Q3 2021 | $17,000 | -99.7% | 1,034 | -99.7% | 0.00% | -100.0% |
Q2 2021 | $5,712,000 | +9.4% | 312,328 | 0.0% | 0.09% | +16.5% |
Q1 2021 | $5,219,000 | – | 312,328 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 859,910 | $15,728,000 | 3.91% |
Ghost Tree Capital, LLC | 350,000 | $6,402,000 | 1.76% |
COMMODORE CAPITAL LP | 186,405 | $3,409,000 | 1.19% |
Atlas Venture Advisors, Inc. | 209,505 | $3,832,000 | 0.40% |
Fairmount Funds Management LLC | 35,092 | $642,000 | 0.26% |
BVF INC/IL | 350,081 | $6,403,000 | 0.24% |
SILVERARC CAPITAL MANAGEMENT, LLC | 28,399 | $519,000 | 0.23% |
Cormorant Asset Management, LP | 342,962 | $6,273,000 | 0.21% |
Perceptive Advisors | 1,589,012 | $29,062,000 | 0.19% |
RA Capital Management | 312,328 | $5,712,000 | 0.09% |